Tissue Total RNA, Bone
Specifications
| Product Data | |
| Disease State | Cancer |
|---|---|
| Diagnosis Category | Sarcoma |
| Sample ID | FR5B3450AC |
| Case ID | CI7000000197 |
| Prep | 1 |
| Vial ID | RN00003B93 |
| Tissue of Origin | Bone |
| Site of Finding | Lung |
| Appearance | Tumor |
| Sample Diagnosis (from Pathology Verification) | Ewing sarcoma, metastatic |
| Normal | 35% |
| Lesional | 0% |
| Tumor | 60% |
| Tumor Hypo/Acellular Stroma | 0% |
| Tumor Hypercellular Stroma | 5% |
| Necrosis | 0% |
| T (Extent of Primary Tumor) | TX |
| N (Lymph node metastasis) | NX |
| M (Distant metastasis) | M1 |
| CASE Diagnosis (from medical center path report) | Ewing sarcoma, metastatic |
| Age | 51 |
| Gender | Female |
| Tumor Grade | AJCC G3-4: Poorly differentiated or undifferentiated |
| Minimum Stage Grouping | IV |
| Storage | Store tissue total RNA at -80°C. |
| Stability | These products are stable for one year from date of shipping when stored at -80°C without repeated freeze/thaws. |
| Shipping | Dry Ice |
Reviews
Documents
| Datasheet | |
| SDS | |
Citations
Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion
Raimondi, Gallo, Cuscino et al
Int J Mol Sci (2022) 23 (2) DOI: 10.3390/ijms23020705
Raimondi, Gallo, Cuscino et al
Int J Mol Sci (2022) 23 (2) DOI: 10.3390/ijms23020705
Cited by 11
AI Summary: OriGene's Tissue Total RNA from Bone tissue was used in this study to provide reference RNA samples for comparison with osteosarcoma cells, aiding in the analysis of miR-CT3 expression levels.
Snippet: cells transfected for 48 h with synthetic miR-CT3 or scrambled oligonucleotides (NC) was obtained by centrifugating medium at 1000× g for 10 min. Tissue Total RNA from Bone tissue was purchased from Origene (OriGene Technologies GmbH, Rockville, MD, USA). 4.2. Exosome Purification Microvesicles from plasma of metastatic patients were isolated with Total Exosome Isolation Kit (Thermo Fisher Scien
Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells
Chiovaro, Martina, Bottos et al
Int. J. Cancer (2015)
Chiovaro, Martina, Bottos et al
Int. J. Cancer (2015)
Cited by 33
AI Summary: OriGene provided normal bone total RNA and glioblastoma total RNA, which were used for 5′RACE analysis to study tenascin-W transcript variants in this research.
Snippet: constructs. 5′RACE was performed using total RNA from normal bone (OriGene, Rockville, MD), breast cancer tissue (Clontech) and glioblastoma (OriGene) using the 5′/3′RACE Kit (2nd Generation, Roche diagnostics). ... Cite SaveSaving
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
